2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$40.63-$0.07 (-0.18%)
Price as of Oct 23, 2026 4:05 PM EDT- $2.4BMarket Cap
- -19.13%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$40.63-$0.07 (-0.18%)
SUPN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.70 | ||
Change | -$1.37 (-3.26%) | ||
Open | $41.68 | ||
High | $41.95 | ||
Low | $39.96 | ||
Previous Close | $42.07 | ||
Volume | 1,159,336 | ||
30-Day Average Volume | 875,435 | ||
1-Week Change | 7.44% | ||
1-Month Change | -6.20% | ||
1-Year Change | -22.96% | ||
3-Year Change | 71.30% | ||
5-Year Change | 36.58% | ||
Fundamentals | |||
Shares Outstanding | 58.2M | ||
Total Assets | $1.4B | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $165.7M | ||
Net Income | -$58.4M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$57.6M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $376.1M | ||
EPS | -$1.01 | ||
Enterprise Value/EBITDA | -71 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 2 | ||
P/E | -42 | ||
PEG | 0 | ||
Price/Free Cash Flow | -455 | ||
Price/Operating Cash Flow | -509 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue